Test Bank for Clayton’s Basic Pharmacology for Nurses 19th Edition | Verified Q&A | All Chapters

TestyBankyForyClayton’syBasicyPharmacologyyforyNursesy19thyEdition 1




COMPELETE TESTBANK y




TESTBANK FOR CLAYON’S BASIC PHARMACOLOGY F
y y y y y


OR NURSES 19TH EDITION/ WILLIHNGANZ VERIFIEDQU
y y y y y y


ESTIONS AND ANSWERS WITH 2024 UPDATES (ALLCHA
y y y y y y y


PTERS INLUDED 1-48) y y

,TestyBankyForyClayton’syBasicyPharmacologyyforyNursesy19thyEdition 2




Chapter 01: Drug Definitions, Standards, and Information Sources
y y y y y y y y

Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
y y y y y y y




1. WhichynameyidentifiesyaydrugylistedybyytheyUSyFoodyDrugy
Administrationy(FDA)?
a. Bran
b. Nonproprietar
c. Official
d. Trademark
ANS:
Theyofficialynameyisytheynameyunderywhichyaydrugyisylistedybyyth
eyFDA.yTheybrandyname,yorytrademark,yisytheynameygivenytoyayd
rugybyyitsymanufacturer.yTheynonproprietary,yorygeneric,ynameyi
syprovidedybyytheyUnitedyStatesyAdoptedyNamesyCouncil.
CognitiveyLevel:yKnowledge REF:y p.y9
OBJ:y1NAT:yNCLEXyClientyNeedsyCategory:ySafe,yEffectiveyCarey
EnvironmentyTOP:y NursingyProcessyStep:yAssessment
CON:y
PatientyEducation




2. Whichysourceycontainsyinformationyspecificytoynutritionalysupplements?
a. USPyDictionaryyofyUSANy &yInternationalyDrugyNames
b. NaturalyMedicinesyComprehensiveyDatabase
c. UnitedyStatesyPharmacopoeia/NationalyFormularyy(USPyNF)
d. DrugyInteractionyFacts
ANS:y C
UnitedyStatesyPharmacopoeia/NationalyFormularyycontainsyinformationyspecificytoynutritionalys
upplements.yUSPyDictionaryyofyUSANy&yInternationalyDrugyNamesyisyaycompilationyofydrugyna
mes,ypronunciationyguide,yandypossibleyfutureyFDAyapprovedydrugs;yitydoesynotyincludeynutriti
onalysupplements.yNaturalyMedicinesyComprehensiveyDatabaseycontains
evidence-
basedyinformationyonyherbalymedicinesyandyherbalycombinationyproducts;yitydoesynotyincludeyinf
ormationyspecificytoynutritionalysupplements.yDrugyInteractionyFactsycontainsycomprehensiveyi
nformationyonydrugyinteractionyfacts;yitydoesynotyincludeynutritionalysupplements.

DIF: CognitiveyLevel:yKnowledge REF:y p.y4
OBJ:y3yNAT:y NCLEXyClientyNeedsyCategory:yPhysiologicalyIntegr
ity
TOP:y NursingyProcessyStep:yAssessment CON:y Nutritiony|yPatientyEducation

3. Whichydrugyreferenceycontainsydrugymonographsythatydescribeyallydrugsyinyaytherapeuticyclass?
a. DrugyFactsyandyComparisons

,TestyBankyForyClayton’syBasicyPharmacologyyforyNursesy19thyEdition 3

b. DrugyInteractionyFacts
c. HandbookyonyInjectableyDrugs
d. Martindale—TheyCompleteyDrugyReference

ANS:y A
DrugyFactsyandyComparisonsycontainsydrugymonographsythatydescribeyallydrugsyinyaythe
rapeuticyclass.yMonographsyareyformattedyasytablesytoyallowycomparisonyofysimilaryprodu
cts,ybrandynames,ymanufacturers,ycostyindices,yandyavailableydosageyformsyOnlineyversi
onyisyavailable.

DIF: CognitiveyLevel:yKnowledge REF:y p.y4yTabley1.2
OBJ:yyy 3 NAT:y NCLEXyClientyNeedsyCategory:yPhysiologicalyIntegrity
TOP:y NursingyProcessyStep:yAssessment CON:y Safetyy|yPatientyEducationy|yClinicalyJudgment

4. Whichydrugyreferenceycontainsymonographsyaboutyvirtuallyyeveryysingle-
entityydrugyavailableyinytheyUnitedyStatesyandydescribesytherapeuticyusesyofydrugs,yincludingyap
provedyandyunapprovedyuses?
a. Martindale:yTheyCompleteyDrugyReference
b. AHFSyDrugyInformation
c. DrugyReference
d. DrugyFactsyandyComparisons
ANS:y B
AHFSyDrugyInformationycontainsymonographsyaboutyvirtuallyyeveryysingle-
entityydrugyavailableyinytheyUnitedyStatesyandydescribesytherapeuticyusesyofydrugs,yincludingyapp
rovedyandyunapprovedyuses.

DIF: CognitiveyLevel:yKnowledge REF:y p.y4yTabley1.2
OBJ:yyy 3 NAT:y NCLEXyClientyNeedsyCategory:yPhysiologicalyIntegrity
TOP:y NursingyProcessyStep:yPlanning CON:y Safetyy|yPatientyEducationy|yClinicalyJudgment

5. Whichyonlineydrugyreferenceymakesyavailableytoyhealthcareyprovidersyandytheypublicyaystan
dard,ycomprehensive,yup-to-dateylookyupyandydownloadableyresourceyaboutymedicines?
a. AmericanyDrugyIndex
b. AmericanyHospitalyFormulary
c. DailyMed
d. DrugyReference
ANS:y C
DailyMedymakesyavailableytoyhealthcareyprovidersyandytheypublicyaystandard,ycomprehensive,yu
p-to-
dateylookyupyandydownloadableyresourceyaboutymedicines.yTheyAmericanyDrugyIndexyisynotyapp
ropriateyforypatientyuse.yTheyAmericanyHospitalyFormularyyisynotyappropriateyforypatientyuse.y
Theydrugyreferenceyisynotyappropriateyforypatientyuse.

DIF: CognitiveyLevel:yKnowledge REF:y p.y3y|yp.y4
OBJ:y3yNAT:y NCLEXyClientyNeedsyCategory:yPhysiologicalyIntegr
ity
TOP:y NursingyProcessyStep:yImplementation
CON:y Safetyy|yPatientyEducationy|yClinicalyJudgment

6. WhichylegislationyauthorizesytheyFDAytoydetermineytheysafetyyofyaydrugybeforeyitsymarketing?
a. FederalyFood,yDrug,yandyCosmeticyActy(1938)
b. DurhamyHumphreyyAmendmenty(1952)

, TestyBankyForyClayton’syBasicyPharmacologyyforyNursesy19thyEdition 4

c. ControlledySubstancesyActy(1970)
d. KefauveryHarrisyDrugyAmendmenty(1962)
ANS:y A
TheyFederalyFood,yDrug,yandyCosmeticyActyofy1938yauthorizedytheyFDAytoydetermineytheysafet
yyofyallydrugsybeforeymarketing.yLateryamendmentsyandyactsyhelpedytightenyFDAycontrolyandyen
sureydrugysafety.yTheyDurhamyHumphreyyAmendmentydefinesytheykindsyofydrugsythatycannotyb
eyusedysafelyywithoutymedicalysupervisionyandyrestrictsytheirysaleytoyprescriptionybyyaylicensedyp
ractitioner.yTheyControlledySubstancesyActyaddressesyonlyycontrolledysubstancesyandytheirycateg
orization.yTheyKefauveryHarrisyDrugyAmendmentyensuresydrugyefficacyyandygreaterydrugysafety.
yDrugymanufacturersyareyrequiredytoyproveytoytheyFDAytheyeffectiveness yofytheiryproducts ybefor

eymarketingythem.

DIF: CognitiveyLevel:yKnowledge REF:yp.y5yTableyl.3
OBJ:y 5
NAT:yNCLEXyClientyNeedsyCategory:yPhysiologicalyIntegrityy
TOP:y NursingyProcessyStep:yAssessment
CON:y Safetyy|yPatientyEducationy|yEvidencey|yHealthyCareyLaw

7. Whichyclassificationydoesymeperidiney(Demerol)yfallyunder?
a. I
b. II
c. III
d. IV
ANS:y B
Meperidiney(Demerol)yisyayScheduleyIIydrug;yityhasyayhighypotentialyforyabuseyandymayyleadytoyse
vereypsychologicalyandyphysicalydependence.yScheduleyIydrugsyhaveyhighypotentialyforyabuseyand
ynoyrecognized ymedical yuse.yScheduleyIIIydrugs yhaveysomeypotentialyforyabuse.yUseymayyleadyto

ylowytoymoderateyphysicalydependenceyoryhigh ypsychological ydependence. yScheduleyIVydrugsyh

aveylowypotentialyforyabuse.yUseymayyleadytoylimitedyphysicalyorypsychologicalydependence.

DIF: CognitiveyLevel:yKnowledge REF:y p.y10
OBJ:y2yNAT:y NCLEXyClientyNeedsyCategory:ySafe,yEffectiveyCarey
Environment
TOP:y NursingyProcessyStep:yAssessment CON:y PatientyEducationy|yAddictiony|yPain

8. WhichyactionywouldytheyFDAytakeytoyexpediteydrugydevelopmentyandyapprovalyforyanyoutbreakyo
fysmallpox?
a. Listysmallpoxyasyayhealthyorphanydisease.
b. Omitytheypreclinicalyresearchyphase.
c. Extendytheyclinicalyresearchyphase.
d. Fastytrackytheyinvestigationalydrug.
ANS:y D
OnceytheyInvestigationalyNewyDrugyApplicationyhasybeenyapproved,ytheydrugycanyreceiveyhigh
estypriorityywithinytheyagency,ywhichyisycalledyfastytracking.yAysmallpoxyoutbreakywouldybeco
meyaypriorityyconcernyinytheyworld.yOrphanydiseasesyareynotyresearchedyinyaypriorityymanner.yPr
eclinicalyresearchyisynotyomitted.yExtendingyanyyphaseyofytheyresearchywouldymeanyaylongerytim
eytoydevelopyayvaccine.yTheyFDAymustyensureythatyallyphasesyofytheypreclinicalyandyclinicalyresea
rchyphaseyhaveybeenycompletedyinyaysafeymanner.

DIF: CognitiveyLevel:yKnowledge REF:y p.y7 OBJ:y 5